Clinical Trial

Genetic Testing in African Americans

Study acronym: GTM-I
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a pilot/feasibility study to conduct genetic testing using tumor/blood samples of African American and Caucasian patients with ovarian and endometrial cancer following surgery at AU Health Medical Center. The aim of the pilot/feasibility study is to sequence a panel of cancer genes on paired tumor/blood (germline) samples of patients with ovarian and endometrial tumors at a two-week time point following surgery at AU Medical Center. While paired testing of tumor and blood (germline) provides direct clinical value to patients, investigators propose to study whether investigators can define and overcome such minority barriers among the Georgia Cancer Center (GCC)/AU Health Medical Center (AUMC) patient population.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-10-19; most recent amendment 2025-02-20.
Status change: Recruiting → Active, Not Recruiting 2025-02-20
Status change: Not Yet Recruiting → Recruiting 2023-07-20
Trial Details
NCT Number NCT05591131
Lead Sponsor Augusta University
Conditions Ovarian Cancer, Endometrial Cancer, Peritoneal Cancer
Enrollment 21 participants
Start Date 2023-04-20
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2025-02-21